Basic Information
TNK Therapeutics is a subsidiary of Sorrento. TNK focuses on the development and commercialization of cell therapies to address unmet medical needs in the field of oncology. TNK technology reprograms immune cells to recognize and effectively kill cancer cells.
TNK Therapeutics, Inc.
SanDiego,California,United States of America
less than 15 people
January 01, 2015
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios